In-Office Blood Lead Testing

As of November 5, 2012, Maine law External site disclaimer allows approved providers to perform in-office blood lead testing of children under age 6 years using a CLIA-waived, direct-read blood lead analyzer and to electronically report all test results to the Maine Childhood Lead Poisoning Prevention Program. (Read the rules related to the law. External site disclaimer)

  • doctor examining child's fingerThe intent of the law is to increase blood lead testing of children under age 6 years.
  • Currently, the only CLIA-waived, in-office, direct-read blood lead testing device is the LeadCare II External site disclaimer, made by Magellan Diagnostics.
  • Providers must have approval from the Maine Childhood Lead Poisoning Prevention Program before they can begin in-office testing. The purpose of the approval is to ensure 1) that in-office blood lead testing will remove barriers to testing; and, 2) that providers using in-office testing will be able to have complete, timely, and electronic reporting of all test results directly to Maine Childhood Lead Poisoning Prevention Program.
  • All elevated blood lead levels still require a venous confirmation through the State Health and Environmental Testing Laboratory. See our recommended follow-up schedule for more information.
  • For questions about the law, approval process, or data reporting requirements, contact: Eric Frohmberg, Manager, Childhood Lead Poisoning Prevention Program, 207-287-8141 or eric.frohmberg@maine.gov.

    Get information about provider approval: criteria, application process, etc.

    Read about data reporting requirements for in-office blood lead testing.